Oncolytics Biotech Investor Presentation August 2023

Oncolytics Biotech presented its investor overview in August 2023, detailing pelareorep, an intravenously-delivered immunotherapy designed to enhance tumor susceptibility to oncology treatments. The presentation outlines the company's development strategy, clinical milestones, market opportunities, and anticipated catalysts in breast and pancreatic cancer applications.